MannKind reported $1.64M in Interest Income for its fiscal quarter ending in December of 2025.





Interest Income Change Date
Adma Biologics USD 1.09M 717K Mar/2026
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
Eli Lilly USD 65M 25M Sep/2025
Insmed USD 765K 55K Sep/2024
Karyopharm Therapeutics USD -0.15 0.11 Dec/2024
MacroGenics USD 1.55M 26K Mar/2026
MannKind USD 1.64M 991K Dec/2025
Merck USD 69M 27M Dec/2025
Novavax USD 303K 27K Dec/2021
Novo Nordisk DKK 3.42B 2.04B Mar/2025
Pfizer USD 115M 51M Mar/2026
Sanofi EUR 33M 81M Dec/2025
Xencor USD 6.2M 338K Dec/2025